NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 378 filers reported holding NOVAVAX INC in Q1 2022. The put-call ratio across all filers is 1.88 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $171 | -1.7% | 23,588 | +1.0% | 0.00% | 0.0% |
| Q2 2023 | $174 | +3.6% | 23,355 | -3.4% | 0.00% | 0.0% |
| Q1 2023 | $168 | -32.5% | 24,183 | -0.1% | 0.00% | -50.0% |
| Q4 2022 | $249 | -99.9% | 24,201 | -5.8% | 0.00% | -33.3% |
| Q3 2022 | $468,000 | -21.2% | 25,695 | +122.6% | 0.00% | -25.0% |
| Q2 2022 | $594,000 | -45.7% | 11,541 | -22.2% | 0.00% | -33.3% |
| Q1 2022 | $1,093,000 | -45.8% | 14,834 | +5.2% | 0.01% | -33.3% |
| Q4 2021 | $2,017,000 | -44.0% | 14,095 | -18.9% | 0.01% | -52.6% |
| Q3 2021 | $3,603,000 | +88.8% | 17,378 | +93.3% | 0.02% | +72.7% |
| Q2 2021 | $1,908,000 | +52.0% | 8,988 | +29.8% | 0.01% | +57.1% |
| Q1 2021 | $1,255,000 | +119.8% | 6,923 | +35.3% | 0.01% | +133.3% |
| Q4 2020 | $571,000 | +72.0% | 5,117 | +66.8% | 0.00% | +50.0% |
| Q3 2020 | $332,000 | – | 3,067 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 132,500 | $2,414,000 | 0.77% |
| HAP Trading, LLC | 130,000 | $10,673,000 | 0.71% |
| Mendel Capital Management LLC | 23,835 | $434,000 | 0.51% |
| Faithward Advisors, LLC | 115,912 | $2,109,000 | 0.50% |
| Rock Springs Capital Management LP | 599,300 | $10,907,000 | 0.28% |
| SECTOR GAMMA AS | 56,735 | $1,033,000 | 0.27% |
| Quantitative Investment Management, LLC | 83,072 | $1,511,000 | 0.25% |
| LMR Partners LLP | 396,100 | $7,209,000 | 0.13% |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 1,333,706 | $24,273,000 | 0.13% |
| TSP Capital Management Group, LLC | 16,025 | $292,000 | 0.12% |